ميكلوفينوكسات

Meclofenoxate is not FDA-approved in the United States but is sold as a dietary supplement; it is a prescription medication in some countries including Japan and parts of Europe. Individuals with depression, mania, epilepsy, or convulsive disorders should avoid use entirely. The substance is prohibited for athletes under WADA regulations as a stimulant. Quality and purity of supplements vary significantly; only 14% of tested products contained labeled amounts within 10% accuracy. Cycling is recommended with 5 days on and 2 days off to prevent acetylcholine toxicity.

Also known as: Anp 235, Acephen, Lucidril, Helfergin, Centrophenoxine

Classification

Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: Choline derivative
Tag: Cholinergic
Tag: Cognitive-enhancer
Tag: Tentative

Effects

Stamina Enhancement
Stimulation
Increased Heart Rate
Subtle Stimulation
Headache
Gastrointestinal Distress
Focus Enhancement
Memory Enhancement
Wakefulness
Motivation Enhancement
Dream Potentiation
Mindfulness
Bodily Control Enhancement
Visual Acuity Enhancement
Olfactory Intensification
Light Sensitivity
Appetite Suppression
Acuity Enhancement

Routes of Administration

Oral

Dosage

Threshold: 50 mg
Light: 50-200 mg
Common: 250 mg 1-6 x a day
Strong: 800-1000 mg
Heavy: 1000 mg

Duration

Onset: 0.5-1.5 h
Peak: 2-4 h
Offset: 2-4 h
After Effects: 12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu